BDK Final Exam APC V

123456789101112131415161718
Across
  1. 3. IV formulation contains propylene glycol and may be associated with toxicity if used for more than 48 hours
  2. 5. anticoagulant with increased risk of epidural or spinal hematoma in a patient undergoing spinal puncture
  3. 8. antibiotic used for CDI, generic name of Dificid
  4. 9. injection can cause peripheral extravasation, preferred parenteral route is IM
  5. 12. the only fluoroquinolone that does not provide activity against strep pneumo
  6. 13. key side effect of esophagitis
  7. 16. tablets with wax coating may appear in stool
  8. 17. Alpha 2 agonist that must be tapered to reduce rebound HTN
  9. 18. ADHD medication that can also be used for HTN
Down
  1. 1. has a US boxed warning of may cause severe neutropenia
  2. 2. direct arterial vasodilator that can cause a drug-induced lupus-like syndrome
  3. 4. LABA component of Dulera
  4. 6. key side effect of ototoxicity
  5. 7. NDRI that may increase risk of seizures
  6. 10. water soluble vitamin that is not well tolerated due to side effect of flushing
  7. 11. agent used in asthma with a US boxed warning of serious neuropsychiatric effects
  8. 13. anticonvulsant with a US boxed warning of may cause fetal toxicity
  9. 14. patient must remain upright for 60 minutes following dose to reduce esophageal irritation
  10. 15. US Boxed warning of extravasation, central line administration preferred